Luzzatto, Lucio,
Complement in PNH and other hemolytic anaemias part 3 of 3 / [electronic resource] : Complement in Paroxysmal nocturnal hemoglobinuria and other hemolytic anemias. Part 3 Complement in PNH and other hemolytic anaemias. Part 3 Lucio Luzzatto. - London : Henry Stewart Talks, 2017. - 1 online resource (1 streaming video file (27 min.) : color, sound). - The complement system, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Complement system. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Complement-targeted therapy for PNH -- Mechanism of (iatrogenic) hemolysis in PNH -- Pathogenesis of PNH -- Anaemias due to intravascular hemolysis -- Bone marrow failure and PNH -- Somatic mutations in PNH -- Clinical burden of PNH -- PNH: issues in management -- Eculizumab (anti-C5 Ab): targeted therapy for PNH.
Access restricted to subscribers.
Mode of access: World Wide Web.
4541 Henry Stewart Talks
Complement (Immunology)
Hemolytic anemia.
Immunologic diseases.
Paroxysmal hemoglobinuria.
Anemia, Hemolytic.
Antibodies, Monoclonal, Humanized.
Bone Marrow.
Complement Activation--drug effects.
Complement System Proteins.
eculizumab.
Erythrocytes.
Hemoglobinuria, Paroxysmal--drug therapy.
Hemoglobinuria, Paroxysmal--pathology.
Hemolysis--drug effects.
Iatrogenic Disease.
Complement in PNH and other hemolytic anaemias part 3 of 3 / [electronic resource] : Complement in Paroxysmal nocturnal hemoglobinuria and other hemolytic anemias. Part 3 Complement in PNH and other hemolytic anaemias. Part 3 Lucio Luzzatto. - London : Henry Stewart Talks, 2017. - 1 online resource (1 streaming video file (27 min.) : color, sound). - The complement system, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Complement system. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Complement-targeted therapy for PNH -- Mechanism of (iatrogenic) hemolysis in PNH -- Pathogenesis of PNH -- Anaemias due to intravascular hemolysis -- Bone marrow failure and PNH -- Somatic mutations in PNH -- Clinical burden of PNH -- PNH: issues in management -- Eculizumab (anti-C5 Ab): targeted therapy for PNH.
Access restricted to subscribers.
Mode of access: World Wide Web.
4541 Henry Stewart Talks
Complement (Immunology)
Hemolytic anemia.
Immunologic diseases.
Paroxysmal hemoglobinuria.
Anemia, Hemolytic.
Antibodies, Monoclonal, Humanized.
Bone Marrow.
Complement Activation--drug effects.
Complement System Proteins.
eculizumab.
Erythrocytes.
Hemoglobinuria, Paroxysmal--drug therapy.
Hemoglobinuria, Paroxysmal--pathology.
Hemolysis--drug effects.
Iatrogenic Disease.